Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study ( vol 42 , pg 1582 , 2025) Correction

publication date

  • July 12, 2025

webpage

published in